GLP-1 TV
Zepbound (tirzepatide) My 100+ pounds weight loss journey! #glp1 #zepbound
Today’s cheapest Zepbound$348/mo at Lemonaid Health, medication and membership billed separately.Compare all Zepbound prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. Not from the video’s creator.Our summary
The speaker, who runs the channel the channel, introduces her weight loss story with Zepbound (tirzepatide). She says she has lost over 100 pounds in almost two years, about 20 on her own and about 90 with a GLP-1. She stresses that she is not a doctor or nurse. She gives a short background on the drugs, saying Ozempic and Wegovy contain semaglutide and act on GLP-1 alone, while Mounjaro and Zepbound contain tirzepatide and act on GLP-1 and GIP. She cites a study in which the highest Zepbound dose led to about 21% body weight loss over 72 weeks, compared with about 15% on Wegovy after 68 weeks, and says she found this information online.
Published by Ms. Toy The Review on YouTube
As published by the channel. Not medical advice, and not an endorsement.
What else the video covers
She explains why she started. In her 40s she had high blood pressure with emergency visits before a hypertension diagnosis, joint pain, and the deaths of two friends. She says years of Weight Watchers and three years of boxing classes did not solve her eating habits, and she had agreed to consider weight loss surgery. A creator she followed mentioned that Weight Watchers had partnered with a company called Sequence. She says she completed a survey, blood work, and a video visit. Wegovy was approved by insurance but out of stock, metformin gave her about one pound of loss in a month, and her doctor then offered Zepbound, which insurance covered. She started in December 2023 and told no one.
She says she lost about six pounds a month, with a best month of 10 pounds, and her doctor raised her dose every month up to 15. She also talks about the shortage that began around March, about compounded versions, and about not feeling embarrassed to use these medications. She says later videos will cover insurance and paying without it.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:04 She describes high blood pressure, joint pain, and the loss of friends as her reasons for acting.
- 0:08 She says she tried Weight Watchers and boxing for years before turning to medication as a last resort before surgery.
- 0:10 She says Wegovy was approved but out of stock, metformin produced little loss, and Zepbound was then covered by insurance.
- 0:15 She reports losing about six pounds a month, with a best month of 10 pounds.
- 0:20 She says her doctor raised her dose monthly until she reached 15.
- 0:36 She says she lost over 100 pounds, roughly 20 on her own and 90 with a GLP-1.
Key moments
Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Zepbound and tirzepatide
- Weight loss mentioned
- 100 lb
Questions this video answers
How much weight did she lose on Zepbound?
She says she lost over 100 pounds in total, about 20 on her own and about 90 with a GLP-1. On Zepbound she reports losing roughly four to six pounds a month, with a highest month of 10 pounds.
How did she get started on Zepbound?
She says she went through Sequence, a program Weight Watchers partnered with, after a survey, blood work, and a video visit with a doctor. Wegovy was out of stock, so the doctor offered Zepbound once it came out, and she says her insurance covered it.
Did her doctor raise her Zepbound dose every month?
She says her doctor increased her dose every single month because she had a lot to lose and was not losing large amounts. She says she reached the 15 dose, and notes that people today often stay on a dose longer if it is working.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
Will Zepbound be the Key to your Weight Loss?In this video, the speaker, D.O., gives an overview of Zepbound, which he describes as a newly approved weight loss medication that has existed for a few years.- Already on Zepbound? What your next month costs at every programToday’s lowest is $348/mo. Every program ranked by price alone.
MY WEIGHT LOSS JOURNEY | ZEPBOUND, MOUNJARO & TIRZEPATIDE Q&AIn this Q&A video, the creator (who gives her name as the speaker) answers questions she gets about taking Zepbound, which she uses for weight loss.
ZEPBOUND BEATS WEGOVY IN WEIGHT LOSS, According to New Study! Doctor ExplainsThe channel describes a new head-to-head randomized controlled trial that compared Zepbound with Wegovy.
My Entire Tirzepatide GLP-1 Weight Loss Experience | 6 Months On, 6 Months Off | Mounjaro, ZepboundThe channel describes her experience with compounded tirzepatide, which she says is the main ingredient in Mounjaro and Zepbound.
How does Zepbound (tirzepatide) compare to Wegovy (semaglutide)?The speaker, who describes himself as a triple board certified physician and obesity medicine specialist, compares Wegovy (semaglutide) and Zepbound (tirzepatide) in this short explainer.
I've Lost 60 Pounds In 6 Months! An Update On My Weightloss Journey #zepboundThe speaker, who runs the channel, says she has lost 60 lbs in 6 months on tirzepatide.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Mounjaro for weight loss, and why Zepbound exists
Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.
- What is Zepbound? Tirzepatide explained: what it treats, how it works, and what it costs
Zepbound is Eli Lilly's brand of tirzepatide, a once-weekly injection that acts on two hormone receptors, GIP and GLP-1. The FDA label approves it, with diet and exercise, for weight reduction in adults with obesity or overweight plus a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity. In the SURMOUNT-5 trial it produced 20.2% average weight loss at 72 weeks against 13.7% for semaglutide. Lilly sells it self-pay from $299 a month.
- Mounjaro vs Ozempic, and the trial everyone quotes about it
Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.
Next steps
Zepbound prices
Find more like it
Dose changeWeigh-in and resultsCost and insuranceExercise and strength
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.




















